DrugPatentWatch Database Preview
Investigational Drug Information for Favipiravir
Email this page to a colleague
What is the drug development status for Favipiravir?
Favipiravir is an investigational drug.
There have been 72 clinical trials for Favipiravir.
The most recent clinical trial was a Phase 3 trial, which was initiated on April 20th 2020.
The most common disease conditions in clinical trials are COVID-19, Coronavirus Infections, and Infection. The leading clinical trial sponsors are MDVI, LLC, Novagenix Bioanalytical Drug R&D Center, and Farmagen Ar-Ge Biyot. Ltd. Sti.
There are one hundred and thirty-two US patents protecting this investigational drug and one international patent.
Summary for Favipiravir
| US Patents | 132 |
| International Patents | 1,382 |
| US Patent Applications | 428 |
| WIPO Patent Applications | 474 |
| Japanese Patent Applications | 148 |
| Clinical Trial Progress | Phase 3 (2020-04-20) |
| Vendors | 91 |
Recent Clinical Trials for Favipiravir
| Title | Sponsor | Phase |
|---|---|---|
| A Double-blind Randomized Controlled Trial of Ivermectin With Favipiravir in Mild-to-moderate COVID-19 Patients | Prince of Songkla University | Phase 2 |
| A Double-blind Randomized Controlled Trial of Ivermectin With Favipiravir in Mild-to-moderate COVID-19 Patients | Mahidol University | Phase 2 |
| Favipiravir +/- Nitazoxanide: Early Antivirals Combination Therapy in COVID-19 | Centro de Investigacion y Estudios Avanzados del Instituto Politecnico Nacional (CINVESTAV) | Phase 2 |
Clinical Trial Summary for Favipiravir
Top disease conditions for Favipiravir
Top clinical trial sponsors for Favipiravir
US Patents for Favipiravir
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| Favipiravir | ⤷ Sign up for a Free Trial | Methods and compositions for inhibition of polymerase | BioCryst Pharmaceuticals, Inc. (Durham, NC) | ⤷ Sign up for a Free Trial |
| Favipiravir | ⤷ Sign up for a Free Trial | Methods of preparing inhibitors of influenza viruses replication | Vertex Pharmaceuticals Incorporated (Boston, MA) | ⤷ Sign up for a Free Trial |
| Favipiravir | ⤷ Sign up for a Free Trial | Viral prophylaxis treatment methods and pre-exposure prophylaxis kits | ELIAN LLC (Monrovia, CA) | ⤷ Sign up for a Free Trial |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for Favipiravir
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| Favipiravir | Australia | AU2011315902 | 2030-10-15 | ⤷ Sign up for a Free Trial |
| Favipiravir | Australia | AU2017200471 | 2030-10-15 | ⤷ Sign up for a Free Trial |
| Favipiravir | Brazil | BR112013009029 | 2030-10-15 | ⤷ Sign up for a Free Trial |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
